PODx Trial: A randomised-controlled trial of Omnipod®5 automated insulin delivery system commenced within 7 days of diagnosis of type 1 diabetes mellitus in children, and adolescents and adults.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2025
This article has no abstract
Epistemonikos ID: eacda04f7966353b327dee1dcf98ebd379ae3c8c
First added on: Apr 24, 2025